These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28676198)

  • 21. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
    Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
    Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and cons.
    Biesenbach G; Pohanka E
    Minerva Urol Nefrol; 2012 Sep; 64(3):173-82. PubMed ID: 22971682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myoclonus in renal failure: Two cases of gabapentin toxicity.
    Kaufman KR; Parikh A; Chan L; Bridgeman M; Shah M
    Epilepsy Behav Case Rep; 2014; 2():8-10. PubMed ID: 25667856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure.
    Hosseini-Zare MS; Dashti-Khavidaki S; Mahdavi-Mazdeh M; Ahmadi F; Akrami S
    Clin Neurol Neurosurg; 2012 Jul; 114(6):663-7. PubMed ID: 22296650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

  • 29. Elderly diabetic patients on peritoneal dialysis.
    Passadakis P; Oreopoulos DG
    Adv Perit Dial; 2009; 25():140-6. PubMed ID: 19886336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myoclonias secondary to gabapentin in a patient with chronic renal failure].
    Prieto-Pérez L; Montastruc J; García-Ruiz PJ
    Rev Neurol; 2011 Apr; 52(8):512. PubMed ID: 21425106
    [No Abstract]   [Full Text] [Related]  

  • 31. Akathisia induced by gabapentin withdrawal.
    See S; Hendriks E; Hsiung L
    Ann Pharmacother; 2011 Jun; 45(6):e31. PubMed ID: 21652784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentration of haptoglobin, adequacy of peritoneal dialysis, and nutrition status of patients with and without diabetes on peritoneal dialysis.
    Sucharzewska-Tomczak M; Grzegorzewska AE; Leander M
    Adv Perit Dial; 2003; 19():246-50. PubMed ID: 14763072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain assessment and management for a dialysis patient with diabetic peripheral neuropathy.
    Innis J
    CANNT J; 2006; 16(2):12-7, 20-6; quiz 18-9, 27-8. PubMed ID: 16875290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal dialysis underscores its merits in portal hypertensionrelated and nephrogenic ascites.
    de Fijter CW; Leijdekkers V; van Leeuwen DJ; Smets YF; Groeneveld JO
    Neth J Med; 2016 Nov; 74(9):383-386. PubMed ID: 27905303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myoclonus and Altered Mental Status Induced by Single Dose of Gabapentin in a Patient With End-Stage Renal Disease: A Case Report and Literature Review.
    Yeddi A; Adam O; Khalid M; Benjaram S; Abu-Heija A; Abdallah MA; Shah P
    Am J Ther; 2019; 26(6):e768-e770. PubMed ID: 30839320
    [No Abstract]   [Full Text] [Related]  

  • 36. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
    Ruessmann HJ;
    J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic patients on peritoneal dialysis.
    Passadakis PS; Oreopoulos DG
    Semin Dial; 2010; 23(2):191-7. PubMed ID: 20525108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rhabdomyolysis from gabapentin: a case report].
    Falconi D; Tattoli F; Brunetti C; De Prisco O; Gherzi M; Marazzi F; Marengo M; Serra I; Tamagnone M; Formica M
    G Ital Nefrol; 2015; 32(2):. PubMed ID: 26005946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.
    Weinhandl ED; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2016 Jan; 67(1):98-110. PubMed ID: 26319755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.